A Prospective Look at Sudden Cardiac Arrest Rates During the COVID-19 Pandemic
Researchers examined the effect of COVID-19 on sudden cardiac arrest during a 2-year period of the pandemic.
Researchers examined the effect of COVID-19 on sudden cardiac arrest during a 2-year period of the pandemic.
A study was conducted to determine the effect of aspirin on 28-day mortality following admission to the intensive care unit.
Increases in PULS Cardiac Test scores after mRNA vaccinations suggest a significantly higher risk of developing acute coronary syndrome, according to findings presented at AHA 2021.
Researchers at AHA 2021 presented their findings from a study that compared CVD risk factors and in-hospital outcomes in young, Black US adults a decade apart.
Researchers conducted a direct comparison between unmasked 0/1-hour hs-cTnT protocol and standard practice masked 0/3-hour hs-cTnT protocol to determine late outcomes in suspected ACS.
Investigators analyzed mortality and clinical, laboratory, and echocardiography parameters possibly impacting health outcomes in BCPE vs BCNE.
Here are highlights from the American Heart Association and American Stroke Association’s 2021 evidence-based guidelines for preventing another stroke after a first stroke or transient ischemic attack.
Researchers found an additive benefit with rivaroxaban in combination with aspirin in terms of event reduction.
HOPE-3 was designed to assess if reducing BP and/or LDL-C would reduce cardiovascular events in study participants at intermediate risk with no prior cardiovascular events.
This study aimed to assess the effects of the various elements of metabolic syndrome on carotid plaque destabilization.